Core Viewpoint - The company aims to become a global leader in the high-end nutrition and health industry, demonstrating strong growth across its three core business units and maintaining healthy profitability and cash flow [2][30]. Group 1: Financial Performance - In 2025, the company reported a revenue of 14.35 billion RMB, a year-on-year increase of 10.3%. The adjusted EBITDA margin was 14.3%, and the adjusted net profit margin was 4.6%, reflecting a 22.7% increase year-on-year [2]. - The revenue from the Chinese market reached 10.20 billion RMB, growing by 17.5% and contributing 71.1% to the total revenue [2]. Group 2: Adult Nutrition and Care (ANC) Business - The ANC business generated revenue of 6.95 billion RMB, a 4.4% increase, accounting for 48.4% of total revenue. Swisse achieved a 13.3% growth in the Chinese market, representing 70.7% of ANC sales [6]. - Swisse reached a milestone of 1 billion USD in global revenue in 2025 and maintained its No.1 position in the vitamin, herbal, and mineral supplements market in mainland China [2][5]. Group 3: Infant Nutrition and Care (BNC) Business - The BNC business reported revenue of 5.26 billion RMB, a 20% increase, making up 36.6% of total revenue. The sales of infant formula in mainland China grew by 28.3%, significantly outpacing the overall market growth [15][31]. - The market share of the ultra-premium infant formula brand reached a historical high of 17.1% [3]. Group 4: Pet Nutrition and Care (PNC) Business - The PNC business achieved revenue of 2.15 billion RMB, an 8.7% increase, contributing 15.0% to total revenue. High-end pet nutrition products saw a 14.3% growth [4][24]. - In North America, the Zesty Paws brand maintained a strong growth rate of 12.8%, while the overall PNC business in North America grew by 7.5% [26]. Group 5: Strategic Initiatives and Future Outlook - The company is focused on optimizing its capital structure, reducing the net leverage ratio from 3.99 times in 2024 to 3.45 times in 2025, while maintaining a cash reserve of over 1.7 billion RMB [4][30]. - The company plans to continue driving growth through high-quality innovation, expanding its product offerings in the nutrition and infant formula sectors, and enhancing its market presence in both domestic and international markets [30][32].